Функциональная гипоталамическая аменорея: этиология и патогенез, роль генетических факторов

1. Roberts R.E., Farahani L., Webber L., Jayasena C. Current understanding of hypothalamic amenorrhoea. Ther. Adv. Endocrinol. Metab. 2020; 11: 2042018820945854. https://dx.doi.org/10.1177/2042018820945854
2. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil. Steril. 2024; 122(1): 52-61. https://dx.doi.org/10.1016/j.fertnstert.2024.02.001
3. Morrison A.E., Fleming S., Levy M.J. A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors. Clin. Endocrinol. (Oxf). 2021; 95(2): 229-38. https://dx.doi.org/10.1111/cen.14399
4. Walsh B.T., Hagan K.E., Lockwood C. A systematic review comparing atypical anorexia nervosa and anorexia nervosa. Int. J. Eat. Disord. 2023; 56(4): 798-820. https://dx.doi.org/10.1002/eat.23856
5. Москвичева Ю.Б., Гусев Д.В., Табеева Г.И., Чернуха Г.Е. Оценка питания, состава тела и особенности диетологического консультирования пациенток с функциональной гипоталамической аменореей. Вопросы питания. 2018; 87(1): 85-91.
6. Бондаренко К.Р., Казанцева В.Д., Доброхотова Ю.Э. Функциональная гипоталамическая аменорея в практике клинициста: лечебно-диаг­ностические особенности. Акушерство и гинекология. 2022; 5: 149-56.
7. Чернуха Г.Е., Бобров А.Е., Гусев Д.В., Табеева Г.И., Никитина Т.Е., Агамамедова И.Н. Психопатологические особенности и эндокринно-метаболический профиль пациенток с функциональной гипоталамической аменореей. Акушерство и гинекология. 2019; 2: 105-12.
8. Шпаков А.О., Деркач К.В. Гонадолиберин – синтез, секреция, молекулярные механизмы и мишени действия. Acta Biomed. Sci. 2019; 4(2): 9-17.
9. Ryterska K., Kordek A., Załęska P. Has menstruation disappeared? Functional hypothalamic amenorrhea-What is this story about? Nutrients. 2021; 13(8): 2827. https://dx.doi.org/10.3390/nu13082827
10. Moore A.M., Coolen L.M., Lehman M.N. Kisspeptin/Neurokinin B/Dynorphin (KNDy) cells as integrators of diverse internal and external cues: evidence from viral-based monosynaptic tract-tracing in mice. Sci. Rep. 2019; 9(1): 14768. https://dx.doi.org/10.1038/s41598-019-51201-0
11. Stamatiades G.A., Kaiser U.B. Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression. Mol. Cell. Endocrinol. 2018; 463: 131-41. https://dx.doi.org/10.1016/j.mce.2017.10.015
12. Męczekalski B., Niwczyk O., Battipaglia C., Troia L., Kostrzak A., Bala G. et al. Neuroendocrine disturbances in women with functional hypothalamic amenorrhea: an update and future directions. Endocrine. 2024; 84(3): 769-85. https://dx.doi.org/10.1007/s12020-023-03619-w
13. Boegl M., Dewailly D., Marculescu R., Steininger J., Ott J., Hager M. The LH:FSH ratio in functional hypothalamic amenorrhea: an observational study. J. Clin. Med. 2024; 13(5): 1201. https://dx.doi.org/10.3390/jcm13051201
14. Pape J., Herbison A.E., Leeners B. Recovery of menses after functional hypothalamic amenorrhoea: if, when and why. Hum. Reprod. Update. 2021; 27(1): 130-53. https://dx.doi.org/10.1093/humupd/dmaa032
15. Behary P., Comninos A.N. Bone perspectives in functional hypothalamic amenorrhoea: an update and future avenues. Front. Endocrinol. (Lausanne). 2022; 13: 923791. https://dx.doi.org/10.3389/fendo.2022.923791
16. Абсатарова Ю.С., Евсеева Ю.С., Андреева Е.Н., Шереметьева Е.В., Григорян О.Р., Михеев Р.К. Трудности дифференциальной диагностики функциональной гипоталамической аменореи и синдрома поли­кистозных яичников: систематический обзор. Проблемы эндокринологии. 2025; 71(1): 83-91.
17. Workman C., Blalock D.V., Mehler P.S. Bone density status in a large population of patients with anorexia nervosa. Bone. 2020; 131: 115161. https://dx.doi.org/10.1016/j.bone.2019.115161
18. Meczekalski B., Katulski K., Czyzyk A., Podfigurna-Stopa A., Maciejewska-Jeske M. Functional hypothalamic amenorrhea and its influence on women’s health. J. Endocrinol. Invest. 2014; 37(11): 1049-56. https://dx.doi.org/10.1007/s40618-014-0169-3
19. Pruneti C., Guidotti S. Cognition, behavior, sexuality, and autonomic responses of women with hypothalamic amenorrhea. Brain Sci. 2022; 12(11): 1448. https://dx.doi.org/10.3390/brainsci12111448
20. Бобров А.Е., Ильина Н.А. Психические расстройства у женщин, страдающих частыми формами вторичной аменореи: нозографическая структура и психологические маркеры. Российский психиатрический журнал. 2022; 5: 74-83.
21. Bonazza F., Politi G., Leone D., Vegni E., Borghi L. Psychological factors in functional hypothalamic amenorrhea: a systematic review and meta-analysis. Front. Endocrinol. (Lausanne). 2023; 14: 981491. https://dx.doi.org/10.3389/fendo.2023.981491
22. Podfigurna A., Maciejewska-Jeske M., Meczekalski B., Genazzani A.D. Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea. Endocrine. 2020; 70(3): 635-43. https://dx.doi.org/10.1007/s12020-020-02481-4
23. Hofmann T., Elbelt U., Haas V., Ahnis A., Klapp B.F., Rose F. Sa1999 kisspeptin is inversely associated with exercise in patients with anorexia nervosa. Gastroenterology. 2016; 150(4): S428. https://dx.doi.org/10.1016/S0016-5085(16)31487-1
24. Hu X., Wang Z., Wang W., Cui P., Kong C., Chen X. et al. Irisin as an agent for protecting against osteoporosis: a review of the current mechanisms and pathways. J. Adv. Res. 2024; 62: 175-86. https://dx.doi.org/10.1016/j.jare.2023.09.001
25. Patel A.H., Koysombat K., Pierret A., Young M., Comninos A.N., Dhillo W.S. et al. Kisspeptin in functional hypothalamic amenorrhea: pathophysiology and therapeutic potential. Ann. N. Y. Acad. Sci. 2024; 1540(1): 21-46. https://dx.doi.org/10.1111/nyas.15220
26. Mahdavi K., Zendehdel M., Zarei H. Decoding the role of ghrelin and its interactions with central signaling pathways in avian appetite regulation. Vet. Res. Commun. 2025; 49(2): 73. http://dx.doi.org/10.1007/s11259-025-10644-9
27. Saadedine M., Berga S.L., Faubion S.S., Shufelt C.L. The silent pandemic of stress: impact on menstrual cycle and ovulation. Stress. 2025; 28(1): 2457767. https://dx.doi.org/10.1080/10253890.2025.2457767
28. Perakakis N., Upadhyay J., Ghaly W., Chen J., Chrysafi P., Anastasilakis A.D. et al. Regulation of the activins-follistatins-inhibins axis by energy status: impact on reproductive function. Metabolism. 2018; 85: 240-9. https://dx.doi.org/10.1016/j.metabol.2018.05.003
29. Gifford R.M., O'Leary T.J., Wardle S.L., Double R.L., Homer N.Z.M., Howie A.F. et al. Reproductive and metabolic adaptation to multistressor training in women. Am. J. Physiol. Endocrinol. Metab. 2021; 321(2): E281-91. https://dx.doi.org/10.1152/ajpendo.00019.2021
30. Абдулкадырова З.К., Абашова Е.И. Значение ингибина как маркера состояния репродуктивной системы. Часть 1. Журнал акушерства и женских болезней. 2019; 68(3): 61-70.
31. Young J. Does genetic susceptibility of the gonadotropic axis explain the variable impact of stressors causing functional hypothalamic amenorrhea? J. Clin. Endocrinol. Metab. 2021; 106(3): e1473-5. https://dx.doi.org/10.1210/clinem/dgaa677
32. Caronia L.M., Martin C., Welt C.K., Sykiotis G.P., Quinton R., Thambundit A. et al. A Genetic basis for functional hypothalamic amenorrhea. N. Engl. J. Med. 2011; 364(3): 215-25. https://dx.doi.org/10.1056/NEJMoa0911064
33. Klein D.A., Emerick J.E., Sylvester J.E., Vogt K.S. Disorders of puberty: an approach to diagnosis and management. Am. Fam. Physician. 2017; 96(9): 590-9.
34. Кокорева К.Д., Чугунов И.С., Безлепкина О.Б. Врожденный изолированный гипогонадотропный гипогонадизм: клинический и молекулярно-генетический полиморфизм. Проблемы эндокринологии. 2021; 67(4): 46-56.
35. Delaney A., Burkholder A.B., Lavender C.A., Plummer L., Mericq V., Merino P.M. et al. Increased burden of rare sequence variants in GnRH-associated genes in women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 2021; 106(3): e1441-52. https://dx.doi.org/10.1210/clinem/dgaa609
36. Lippincott M.F., Schafer E.C., Hindman A.A., He W., Brauner R., Delaney A. et al. Contributions of common genetic variants to constitutional delay of puberty and idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2024; 110(1): e61-7. https://dx.doi.org/10.1210/clinem/dgae166
37. Cangiano B., Swee D.S., Quinton R., Bonomi M. Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease. Hum. Genet. 2021; 140(1): 77-111. https://dx.doi.org/10.1007/s00439-020-02147-1
38. Amato L.G.L., Montenegro L.R., Lerario A.M., Jorge A.A.L., Guerra Junior G., Schnoll C. et al. New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism. Eur. J. Endocrinol. 2019; 181(2): 103-19. https://dx.doi.org/10.1530/EJE-18-0764
39. Kałużna M., Budny B., Rabijewski M., Dubiel A., Trofimiuk-Müldner M., Szutkowski K. et al. Variety of genetic defects in GnRH and hypothalamic-pituitary signaling and development in normosmic patients with IHH. Front. Endocrinol. (Lausanne). 2024; 15: 1396805. https://dx.doi.org/10.3389/fendo.2024.1396805
40. Topaloglu A.K., Turan I. Genetic etiology of idiopathic hypogonadotropic hypogonadism. Endocrines. 2022; 3(1): 1-15. https://dx.doi.org/10.3390/endocrines3010001
41. Lippincott M.F., Xu W., Smith A.A., Miao X., Lafont A., Shennib O. et al. The p190 RhoGAPs, ARHGAP35, and ARHGAP5 are implicated in GnRH neuronal development: evidence from patients with idiopathic hypogonadotropic hypogonadism, zebrafish, and in vitro GAP activity assay. Genet. Med. 2022; 24(12): 2501-15. https://dx.doi.org/10.1016/j.gim.2022.08.025
42. Sun B., Stockman S., Stamou M., Plummer L., Salnikov K., Kotan D. et al. 9242 SOX11 mutations cause hypogonadotropic hypogonadism through both hypothalamic and pituitary level deficits. J. Endocr. Soc. 2024; 8(Suppl. 1): bvae163.1756. https://dx.doi.org/10.1210/jendso/bvae163.1756
43. Al Sayed Y., Howard S.R. Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism – a clinical perspective. Eur. J. Hum. Genet. 2023; 31(4): 387-94. https://dx.doi.org/10.1038/s41431-022-01261-0
44. Gonçalves C., Bastos M., Pignatelli D., Borges T., Aragüés J.M., Fonseca F. et al. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform. Fertil. Steril. 2015; 104(5): 1261-7.e1. https://dx.doi.org/10.1016/j.fertnstert.2015.07.1142
45. Barbagallo F., Bosoni D., Perone V., Cucinella L., Dealberti D., Cannarella R. et al. Gene-environment interaction in functional hypothalamic amenorrhea. Front. Endocrinol. (Lausanne). 2024; 15: 1423898. https://dx.doi.org/10.3389/fendo.2024.1423898
46. Zannas A.S., Wiechmann T., Gassen N.C., Binder E.B. Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology. 2016; 41(1): 261-74. https://dx.doi.org/10.1038/npp.2015.235
47. Lind M.J., Marraccini M.E., Sheerin C.M., Bountress K., Bacanu S.A., Amstadter A.B. et al. Association of posttraumatic stress disorder with rs2267735 in the ADCYAP1R1 gene: a meta-analysis. J. Trauma Stress. 2017; 30(4):389-98. https://dx.doi.org/10.1002/jts.22211
48. Donato K., Ceccarini M.R., Dhuli K., Bonetti G., Medori M.C., Marceddu G. et al. Gene variants in eating disorders. Focus on anorexia nervosa, bulimia nervosa, and binge-eating disorder. J. Prev. Med. Hyg. 2022; 63(2 Suppl. 3): E297-305. https://dx.doi.org/10.15167/2421-4248/jpmh2022.63.2S3.2772
49. Kang Q., Chen J., Yu Sh., Yuan A., Zhang Y., Zhang R. et al. Association of the 5-HT(2A) receptor gene promoter polymorphism-1438G/A with anorexia nervosa and psychopathological traits in the Chinese Han population: a preliminary study. Asia-Pacific Psych. 2017; 9(3): 12284. https://dx.doi.org/10.1111/appy.12284
50. Yan P., Gao B., Wang S., Wang S., Li J., Song M. Association of 5-HTR2A -1438A/G polymorphism with anorexia nervosa and bulimia nervosa: a meta-analysis. Neurosci. Lett. 2021; 755: 135918. https://dx.doi.org/10.1016/j.neulet.2021.135918

Поступила 09.10.2025

Принята в печать 01.11.2025